Skin Treatment (Pharmacies) - Asia

  • Asia
  • Revenue in the Skin Treatment market is projected to reach US$6.08bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.25%, resulting in a market volume of US$7.46bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.34 are generated in 2024.

Key regions: Canada, United States, France, Europe, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in Asia is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences in the Skin Treatment (Pharmacies) market in Asia are shifting towards products that offer multiple benefits. Customers are increasingly seeking skincare products that not only treat specific skin concerns but also provide additional features such as sun protection, anti-aging properties, and hydration. This preference for multi-functional products is driving the demand for innovative formulations and ingredients in the market. Trends in the market indicate a growing focus on natural and organic skincare products. Consumers in Asia are becoming more conscious of the ingredients used in skincare products and are actively seeking out products that are free from harmful chemicals and artificial additives. This trend is driving the demand for natural and organic skincare brands, which are perceived to be safer and more environmentally friendly. Another trend in the Skin Treatment (Pharmacies) market in Asia is the rising popularity of K-beauty products. Korean skincare brands have gained significant popularity in recent years, thanks to their innovative formulations and effective results. The influence of K-beauty trends, such as the 10-step skincare routine, has led to an increased demand for Korean skincare products in the Asian market. Local special circumstances also play a role in the development of the Skin Treatment (Pharmacies) market in Asia. For example, in countries like Japan and South Korea, where skincare is deeply ingrained in the culture, there is a high demand for premium skincare products. These markets are known for their advanced skincare technologies and high-quality formulations, attracting customers who are willing to invest in luxury skincare products. Underlying macroeconomic factors, such as rising disposable incomes and changing demographics, are also driving the growth of the Skin Treatment (Pharmacies) market in Asia. As economies in the region continue to grow, consumers have more purchasing power to spend on skincare products. Additionally, the aging population in many Asian countries is fueling the demand for anti-aging skincare products, creating new opportunities for market growth. In conclusion, the Skin Treatment (Pharmacies) market in Asia is experiencing growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for multi-functional products, natural and organic skincare, and K-beauty brands is driving the market forward, while factors such as cultural preferences and economic growth are also contributing to its positive trajectory.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)